Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TetraVax-DV TV005 Efficacy Against DENV-2 Challenge in Bangladesh
NCT05229354Phase 2Active, not recruiting
- Start
- Dec 2021
- Primary completion
- Nov 2023
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of TetraVax-DV in dengue fever. Started Dec 2021; status: active, not recruiting.
02
Drugs
TetraVax-DV
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT05229354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05229354.